Does Money Buy Years?
Health Spending vs. Life Expectancy

Japan and Switzerland top the rankings at 84+ years, while South Africa and India trail significantly under 70. The chart reveals a striking 18-year gap between the longest- and shortest-lived nations in this sample — a disparity too large to be explained by genetics or chance alone. Notably, several mid-income countries like Cuba and Costa Rica outperform wealthier peers, hinting that factors beyond raw spending (primary care access, diet, social equity) also shape longevity outcomes.

The scatter plot exposes a clear but diminishing-returns relationship. Moving from $500 to $3,000 per capita correlates strongly with longer lifespans. But the United States — at over $12,000 per person — achieves only 77 years, far below peer nations spending half as much. This "American outlier" effect is arguably the most important data story here: beyond a moderate spending threshold, how money is spent matters more than how much.

High-income nations in North America and Western Europe dedicate 10–17 % of their GDP to healthcare, roughly triple the share seen in Sub-Saharan Africa and South/Southeast Asia. Yet the life-expectancy payoff is not always proportional (see Chart 2). This regional comparison reinforces that allocation priority is a political choice — and that nations investing smaller shares of even modest GDPs, like Sri Lanka and Thailand, achieve surprisingly strong health outcomes through efficient primary-care systems.